ART Fertility Clinics, a global leader in reproductive medicine, recently partnered with the Mumbai Obstetric & Gynecological Society (MOGS) to host the Annual Conference 2025 – Lab to Life’ in Mumbai. The event brought together an esteemed panel of international and Indian experts in reproductive medicine to discuss advancements in reproductive health, including gynecology, embryology, and Assisted Reproductive Technology (ART).
Backed by globally renowned fertility specialists and advanced laboratories, ART Fertility Clinics India ensures tailored, evidence-based treatments with high success rates in assisted reproduction. Being committed to ethical practices, transparency, and emotional well-being, ART Fertility Clinics has gained prominence as a trusted choice for couples on their journey to parenthood.
The conference saw participation from a wide range of professionals specializing in various domains of reproductive health. The profiles of speakers and attendees included fertility specialists, gynecologists, embryologists, clinicians, researchers, and lab technologists. Leading global experts in the field like Prof. Dr. Human Fatemi, Prof. Dr. Barbara Lawrenz, Prof. Dr. Mustafa Baris Ata, Dr. Laura Melado Vidales, and Dr. Ameet Patki, along with several noteworthy Indian specialists like Dr. Sujata Dalvi, Dr. Meenakshi Dua, Dr. Akash Surana, and Dr. Rajvi Mehta, were present at the conference. The attendees included doctors, postgraduate students, young clinicians, and academic researchers.
Throughout the day, the conclave featured insightful discussions on ovarian stimulation, stem cell applications, and the impact of paternal aging on ART outcomes. Real-life clinical scenarios and efficient treatment practices were presented during a series of interactive panel discussions.
The conclave also covered topics related to the uterine environment, where experts addressed key challenges including thin endometrium and adenomyosis, helped demystify myths and voiced for evidence-based practices. As the day concluded, discussions focused on the evolving role of ART laboratories, expert viewpoints on AI in embryology, and in vitro maturation (IVM), which are shaping the future of fertility care.
Built on years of clinical excellence and personalized care, ART Fertility Clinics is known for its contribution to Assisted Reproductive Technology. Backed by a strong team of ESHRE-certified subspecialists and modern-day embryology labs, the clinics offer high success rates and an elevated Live Birth Rate (LB rt%) based on diverse patient profiles.
Speaking about ART Fertility Clinics’ dedication to new-age reproductive care, Prof. Dr. Human Fatemi, Group Medical Director, ART Fertility Clinics, said, “At ART Fertility Clinics, helping patients achieve parenthood is at the heart of everything we do. While reproduction is a fundamental part of life, around 15-20% of couples face fertility challenges. Our approach is grounded in evidence-based research, and our expert team is dedicated to managing both male and female infertility. Through AI-backed infrastructure and partnerships with esteemed organizations like MOGS, we aim to combine science with hope and engage India’s medical community in helping patients fulfill their dream of parenthood.””
Dr. Somesh Mittal, Chief Executive Office, ART Fertility Clinics, India, added, “Our eleven state-of-the-art clinics bring global standards of fertility care to India. Every aspect of our practice right from diagnostics to procedures is personalized as per the patients. By identifying root causes and adopting research-driven strategies, our team ensures care that is safe, compassionate, and clinically effective, consistently leading to higher pregnancy outcomes.”
Speaking on their rising presence in India, Dr. Parul Katiyar, Medical Director, ART Fertility Clinics India, shared, “Since our launch in 2021, the journey has been full of learnings and excelling in assisted fertility. We've achieved notable success rates, often helping patients conceive with their gametes whilst other clinics suggested donor cycles. Our focus on research and personalized care allows us to extend the benefits of global expertise to every patient.”